Data from the Center for Drug Evaluation of the National Medical Products Administration shows that on August 18, 2026, the application for Shen Kang Ning Tablets by Sichuan Tongyuan Pharmaceutical Group Co., Ltd. was accepted. The acceptance number is CYZB2604212.
Acceptance number CYZB2604212 Drug name: Shen Kang Ning Tablets Drug type: Traditional Chinese medicine Application type: Supplementary application Registration category: None Enterprise name: Sichuan Tongyuan Pharmaceutical Group Co., Ltd.; Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Handling date: August 18, 2026
Tianyancha data shows that Sichuan Tongyuan Pharmaceutical Group Co., Ltd. was established on February 9, 2002. The legal representative is Hu Dingmin. The industry is the manufacture of chemical pharmaceutical preparations. The company type is a limited liability company (natural person investment or holding). The enterprise size is small. The number of employees covered for insurance is 219. The registered capital is RMB 62 million, and the paid-in capital is RMB 46.39 million. The registered address is No. 33, Section 1, Shenzhen Road West, Guanghan City, Deyang City, Sichuan Province. The shareholder information is as follows: Gao Yulin holds 87.0968% (RMB 54 million) with the subscribed capital date May 31, 2027; first shareholding date February 9, 2002. Feng Shuying holds 12.9032% (RMB 8 million) with the subscribed capital date May 31, 2027; first shareholding date June 30, 2005.
Notice: The market is risky, and investment requires caution. This article is published based on third-party databases and does not represent the views of Sina Finance. Any information appearing in this article is for reference only and does not constitute personal investment advice. If there are any discrepancies, please refer to the actual announcements. If you have any questions, please contact biz@staff.sina.com.cn.